The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Genentech (Inst); MedImmune (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Taiho Pharmaceutical; Teva
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo; Roche/Genentech
 
Anna F. Farago
Honoraria - Clinical Care Options; Dava Oncology; Foundation Medicine; Medical Learning Institute
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; AstraZeneca; Bayer; Boehringer Ingelheim; Genentech/Roche; Loxo; PharmaMar
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Ignyta (Inst); Loxo (Inst); Merck (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie/Stemcentrx; AstraZeneca; Bayer; Boehringer Ingelheim; Dava Oncology; Genentech/Roche; Loxo; PharmaMar
 
Birgit Geoerger
No Relationships to Disclose
 
Juneko E. Grilley-Olson
No Relationships to Disclose
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena; Presagia
Honoraria - Adaptimmune; Baxter; Bayer; Merrimack
Consulting or Advisory Role - Adaptimmune; Alphasights; Axiom Biotechnologies; Baxter; Bayer; Eisai; Genentech; Gerson Lehrman Group; GroupH; Guidepoint Global; Janssen; Medscape; Merrimack; Numab; Pfizer; Seagen; Takeda; Trieza Therapeutics
Research Funding - Abbvie; Adaptimmune; Amgen; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Fate Therapeutics; Genentech; Genmab; Ignyta; Infinity Pharmaceuticals; Kite, a Gilead company; Kyowa Hakko Kirin; Lilly; Loxo; MedImmune; Merck; Mirati Therapeutics; miRNA Therapeutics; Molecular Templates; MOLOGEN; National Cancer Institute; Novartis; Pfizer; Seagen; Takeda
Travel, Accommodations, Expenses - Genmab; Loxo; miRNA Therapeutics
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - Perthera
Research Funding - Agios (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Novartis (Inst); OncoMed (Inst)
Travel, Accommodations, Expenses - Foundation Medicine
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
David Simon Ziegler
No Relationships to Disclose
 
Nora Ku
Employment - Loxo
Honoraria - Amgen (I); AstraZeneca (I); bioTheranostics (I); Cascadian Therapeutics (I); Genentech/Roche (I); Macrogenics (I); Novartis (I); Peregrine Pharmaceuticals (I); Pfizer (I); Pierian Biosciences (I)
Travel, Accommodations, Expenses - Amgen (I); AstraZeneca (I); bioTheranostics (I); Genentech/Roche (I); Macrogenics (I); Novartis (I); Peregrine Pharmaceuticals (I); Pfizer (I); Pierian Biosciences (I)
 
Michael Craig Cox
Employment - Amgen; Bayer; Loxo; Merck KGaA
Stock and Other Ownership Interests - Amgen; Bayer; Loxo; Merck KGaA
Patents, Royalties, Other Intellectual Property - US patent 62/318,041 issued to Loxo Oncology. (Inst)
 
Shivani Nanda
Employment - Bayer
 
Barrett H. Childs
Employment - Bayer
 
Francois P. Doz
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celgene (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb